Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Agnosia × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 2 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Nevus, Sebaceous of Jadassohn 1 Neoplasms 1 Carcinoma, Basal Cell 1 Agnosia 1

Interventions

Tramadol 3 Acetaminophen 3 Ketamine 2 Fentanyl 2 Ethanol 2 Bupivacaine 2 Analgesia, Epidural 2 oxycodone-acetaminophen 1 acetaminophen, codeine drug combination 1 acetaminophen, aspirin, caffeine drug combination 1 Varenicline 1 Therapeutics 1 Sodium Chloride 1 Saline Solution 1 Ropivacaine 1 Radiofrequency Ablation 1 Pregabalin 1 Orphenadrine 1 Morphine 1 Methadone 1 Meperidine 1 Magnesium 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Hydromorphone 1 Hydrocodone 1 Gabapentin 1 Entonox 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06947577 2025-08-20

PEMFTEPCHIN

Cairo University

Phase 4 Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡